Kumar Neil — SEC Form 4 filings
SEC reporting owner CIK 1742485. 41 Form 4 filings on record with FilingPulse; latest filed 2026-08-20.
Transaction summary — filings shown
Covers all 41 filings on record, filed 2024-02-21 to 2026-08-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 160 legs across 26 filings — 2,153,936 shares, $108,813,458 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 83.
- Largest priced transaction: sale of 326,932 shares @ $36.29 ($11,863,381) in BridgeBio Pharma, Inc., filed 2025-01-30.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer, Director | 39 | — | 160 legs · 2,153,936 sh · $108,813,458 | 81 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | Director | 1 | — | — | 1 |
| Maze Therapeutics, Inc. (MAZE) | Director | 1 | — | — | 1 |
Form 4 filings — Kumar Neil
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-20 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 1,900 @ $81.15 · Sale (S): 17,279 @ $82.21 · Sale (S): 14,602 @ $82.99 · Sale (S): 1,199 @ $83.77 · Sale (S): 8,100 @ $83.86 · Sale (S): 1,800 @ $84.69 · +1 more | EDGAR |
| 2026-08-18 | 4 | BridgeBio Pharma, Inc. (BBIO) | Option exercise (M): 33,544 · Option exercise (M): 19,599 · Option exercise (M): 11,554 · Option exercise (M): 6,520 · Tax withholding (F): 36,237 @ $79.86 · Option exercise (M): 33,544 (derivative) @ $0 · +3 more | EDGAR |
| 2026-06-18 | 4 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Grant/award (A): 31,675 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 2,200 @ $65.72 · Sale (S): 1,429 @ $66.72 · Sale (S): 15,921 @ $67.74 · Sale (S): 450 @ $68.27 · Sale (S): 2,200 @ $65.72 · Sale (S): 1,429 @ $66.72 · +8 more | EDGAR |
| 2026-05-26 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 2,256 @ $67.57 · Sale (S): 6,725 @ $68.30 · Sale (S): 5,072 @ $69.22 · Sale (S): 11,250 @ $70.48 · Sale (S): 800 @ $70.92 | EDGAR |
| 2026-05-19 | 4 | BridgeBio Pharma, Inc. (BBIO) | Option exercise (M): 33,544 · Option exercise (M): 19,599 · Option exercise (M): 11,553 · Option exercise (M): 6,519 · Tax withholding (F): 36,236 @ $66.13 · Option exercise (M): 33,544 (derivative) @ $0 · +3 more | EDGAR |
| 2026-05-11 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 11,217 @ $67.50 · Sale (S): 8,333 @ $68.38 · Sale (S): 450 @ $69.09 · Sale (S): 11,217 @ $67.49 · Sale (S): 8,334 @ $68.38 · Sale (S): 449 @ $69.09 · +6 more | EDGAR |
| 2026-04-13 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 7,200 @ $73.64 · Sale (S): 5,300 @ $74.60 · Sale (S): 7,500 @ $75.55 · Sale (S): 7,072 @ $73.64 · Sale (S): 5,128 @ $74.57 · Sale (S): 7,800 @ $75.53 · +2 more | EDGAR |
| 2026-03-31 | 4 | Maze Therapeutics, Inc. (MAZE) | Grant/award (A): 33,417 (derivative) @ $0 | EDGAR |
| 2026-03-19 | 4 | BridgeBio Pharma, Inc. (BBIO) | Grant/award (A): 40,570 (derivative) @ $0 · Grant/award (A): 104,313 (derivative) @ $0 | EDGAR |
| 2026-03-16 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 14,337 @ $68.48 · Sale (S): 5,363 @ $69.32 · Sale (S): 300 @ $70.15 · Sale (S): 13,885 @ $68.47 · Sale (S): 5,815 @ $69.29 · Sale (S): 300 @ $70.15 · +4 more | EDGAR |
| 2026-02-23 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 18,923 @ $71.03 · Sale (S): 8,528 @ $72.08 · Sale (S): 602 @ $72.80 | EDGAR |
| 2026-02-18 | 4 | BridgeBio Pharma, Inc. (BBIO) | Option exercise (M): 33,544 · Option exercise (M): 19,600 · Option exercise (M): 11,554 · Tax withholding (F): 30,970 @ $75.25 · Option exercise (M): 33,544 (derivative) @ $0 · Option exercise (M): 19,600 (derivative) @ $0 · +1 more | EDGAR |
| 2026-02-12 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 14,201 @ $71.80 · Sale (S): 5,799 @ $72.28 · Sale (S): 14,040 @ $71.80 · Sale (S): 5,960 @ $72.27 · Sale (S): 7,806 @ $70.69 · Sale (S): 3,716 @ $71.44 · +6 more | EDGAR |
| 2026-01-12 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 11,515 @ $73.64 · Sale (S): 8,085 @ $74.38 · Sale (S): 400 @ $75.16 · Sale (S): 11,565 @ $73.65 · Sale (S): 8,135 @ $74.38 · Sale (S): 300 @ $75.20 · +8 more | EDGAR |
| 2025-12-16 | 4 | BridgeBio Pharma, Inc. (BBIO) | Option exercise (M): 60,975 · Tax withholding (F): 30,964 @ $75.15 · Sale (S): 28,311 @ $74.60 · Sale (S): 1,700 @ $75.24 · Option exercise (M): 60,975 (derivative) @ $0 | EDGAR |
| 2025-12-08 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 2,100 @ $73.16 · Sale (S): 12,192 @ $74.42 · Sale (S): 5,708 @ $74.80 · Sale (S): 12,517 @ $73.05 · Sale (S): 7,483 @ $73.76 · Sale (S): 2,100 @ $73.16 · +4 more | EDGAR |
| 2025-11-24 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 6,401 @ $64.97 · Sale (S): 14,299 @ $65.90 · Sale (S): 5,456 @ $66.71 | EDGAR |
| 2025-11-18 | 4 | BridgeBio Pharma, Inc. (BBIO) | Option exercise (M): 33,544 · Option exercise (M): 19,599 · Option exercise (M): 11,554 · Tax withholding (F): 32,855 @ $66.39 · Option exercise (M): 33,544 (derivative) @ $0 · Option exercise (M): 19,599 (derivative) @ $0 · +1 more | EDGAR |
| 2025-11-10 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 12,576 @ $62.91 · Sale (S): 7,324 @ $63.55 · Sale (S): 100 @ $64.39 · Sale (S): 12,492 @ $61.14 · Sale (S): 7,308 @ $61.87 · Sale (S): 200 @ $62.80 · +6 more | EDGAR |
| 2025-10-10 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 8,706 @ $54.39 · Sale (S): 11,294 @ $55.09 · Sale (S): 20,000 @ $54.80 · Sale (S): 8,705 @ $54.39 · Sale (S): 11,295 @ $55.09 · Sale (S): 20,000 @ $54.80 | EDGAR |
| 2025-09-08 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 14,525 @ $51.15 · Sale (S): 5,475 @ $51.85 · Sale (S): 2,300 @ $51.95 · Sale (S): 16,800 @ $53.16 · Sale (S): 900 @ $53.80 · Sale (S): 14,558 @ $51.16 · +4 more | EDGAR |
| 2025-08-22 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 25,728 @ $48.81 · Sale (S): 428 @ $49.25 | EDGAR |
| 2025-08-19 | 4 | BridgeBio Pharma, Inc. (BBIO) | Option exercise (M): 64,697 · Tax withholding (F): 32,855 @ $51.32 · Option exercise (M): 33,544 (derivative) @ $0 · Option exercise (M): 19,599 (derivative) @ $0 · Option exercise (M): 11,554 (derivative) @ $0 | EDGAR |
| 2025-08-11 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 6,784 @ $45.09 · Sale (S): 13,216 @ $45.64 · Sale (S): 11,795 @ $45.88 · Sale (S): 8,205 @ $46.71 · Sale (S): 6,784 @ $45.09 · Sale (S): 13,216 @ $45.64 · +2 more | EDGAR |
| 2025-07-03 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 18,300 @ $42.50 · Sale (S): 1,700 @ $42.88 · Sale (S): 20,000 @ $42.73 · Sale (S): 18,400 @ $42.51 · Sale (S): 1,600 @ $42.89 · Sale (S): 20,000 @ $42.73 | EDGAR |
| 2025-05-20 | 4 | BridgeBio Pharma, Inc. (BBIO) | Option exercise (M): 64,696 · Tax withholding (F): 32,854 @ $33.84 · Sale (S): 25,756 @ $33.32 · Sale (S): 400 @ $33.75 · Sale (S): 75,000 @ $33.40 · Option exercise (M): 33,544 (derivative) @ $0 · +2 more | EDGAR |
| 2025-04-24 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 75,000 @ $34.11 | EDGAR |
| 2025-03-27 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 75,000 @ $36.87 | EDGAR |
| 2025-03-21 | 4 | BridgeBio Pharma, Inc. (BBIO) | Grant/award (A): 71,208 (derivative) @ $0 · Grant/award (A): 184,860 (derivative) @ $0 | EDGAR |
| 2025-02-27 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 37,899 @ $33.36 · Sale (S): 37,101 @ $33.79 | EDGAR |
| 2025-02-19 | 4 | BridgeBio Pharma, Inc. (BBIO) | Option exercise (M): 55,539 · Tax withholding (F): 23,996 @ $34.90 · Sale (S): 31,467 @ $36.14 · Sale (S): 76 @ $36.56 · Option exercise (M): 2,395 (derivative) @ $0 · Option exercise (M): 33,544 (derivative) @ $0 · +1 more | EDGAR |
| 2025-01-30 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 326,932 @ $36.29 · Sale (S): 269,068 @ $36.34 · Sale (S): 4,000 @ $36.82 | EDGAR |
| 2024-12-27 | 4 | BridgeBio Pharma, Inc. (BBIO) | Gift (G): 4,685,725 @ $0 · Gift (G): 4,685,725 @ $0 | EDGAR |
| 2024-12-12 | 4 | BridgeBio Pharma, Inc. (BBIO) | Grant/award (A): 121,951 (derivative) @ $0 | EDGAR |
| 2024-11-20 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 25,514 @ $22.39 · Sale (S): 1,875 @ $22.76 | EDGAR |
| 2024-11-19 | 4 | BridgeBio Pharma, Inc. (BBIO) | Option exercise (M): 55,537 · Tax withholding (F): 28,148 @ $23.72 · Option exercise (M): 2,394 (derivative) @ $0 · Option exercise (M): 33,544 (derivative) @ $0 · Option exercise (M): 19,599 (derivative) @ $0 | EDGAR |
| 2024-08-20 | 4 | BridgeBio Pharma, Inc. (BBIO) | Option exercise (M): 55,537 · Tax withholding (F): 28,148 @ $24.40 · Sale (S): 16,192 @ $24.39 · Sale (S): 11,197 @ $25.13 · Option exercise (M): 2,394 (derivative) @ $0 · Option exercise (M): 33,544 (derivative) @ $0 · +1 more | EDGAR |
| 2024-05-17 | 4 | BridgeBio Pharma, Inc. (BBIO) | Option exercise (M): 60,667 · Tax withholding (F): 30,748 @ $31.04 · Option exercise (M): 5,130 (derivative) @ $0 · Option exercise (M): 2,394 (derivative) @ $0 · Option exercise (M): 33,544 (derivative) @ $0 · Option exercise (M): 19,599 (derivative) @ $0 | EDGAR |
| 2024-03-14 | 4 | BridgeBio Pharma, Inc. (BBIO) | Grant/award (A): 45,140 (derivative) @ $0 · Grant/award (A): 313,588 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | BridgeBio Pharma, Inc. (BBIO) | Option exercise (M): 102,249 · Tax withholding (F): 47,922 @ $37.21 · Option exercise (M): 5,129 (derivative) @ $0 · Option exercise (M): 2,394 (derivative) @ $0 · Option exercise (M): 61,182 (derivative) @ $0 · Option exercise (M): 33,544 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1742485 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →